There is one molecule in the asymmetric unit of the title crystal structure, which is shown in the figure. Tables 1 and  2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
The title compound was obtained according to the literatureknown method for the preparation of 3-cyclohexyl-2-cyclohexylimino-3,4-dihydro-4-oxo-2H-1,3-benzoxazine [4] [5] [6] . To obtain the title compound a mixture of 3,5-diiodo-2-hydroxybenzoic acid (3.90 g, 10 mmol) and N,N′-dicyclohexylcarbodiimide (2.06 g, 10 mmol) dissolved in dry THF (40 mL) was stirred at room temperature for 0.5 h, then it was refluxed for 2 h. Colorless powder precipitates during the cooling to room temperature. After filtration, the filtrate was evaporated to dryness giving a residue that crystallized from methanol. Yield 1.42 g (24.5%). Crystals were obtained by slow evaporation of mixed solution of dichloromethane and ethanol (volume 1:1) at room temperature.
Experimental details
Hydrogen atoms were placed geometrically and refined using a riding model with d(C-H) = 0.93-0.97 Å, U iso (H) = 1.2 Ueq(C) for CH groups.
Discussion
The benzo[e]-1,3-oxazin-4-ones and their derivatives are reported to have pharmaceutically interesting properties, such as allosteric mitogen-activated kinase (MEK) inhibition [7] , osteoclast differentiation and bone resorption inhibition [8] , antimycobacterial activity [9] and antimycobacterial properties [10] . Bond lengths and angles are generally in the normal ranges. The C6, N2 and C15 atoms form a bond angle of 120.1°. The surprizing magnitude of this angle may have sterical reasons. Both cyclohexyl rings exhibit a slightly distorted chair conformation.
